Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Sep;71(9):6526-33.
doi: 10.1128/JVI.71.9.6526-6533.1997.

Minimal truncation of the c-myb gene product in rapid-onset B-cell lymphoma

Affiliations

Minimal truncation of the c-myb gene product in rapid-onset B-cell lymphoma

W Jiang et al. J Virol. 1997 Sep.

Abstract

Oncogenic activation of c-myb by insertional mutagenesis has been implicated in rapid-onset B-cell lymphomas induced by the nonacute avian leukosis virus EU-8. In these tumors, proviruses are integrated either upstream of the c-myb coding region or within the first intron of c-myb. Tumors with either type of integration contained identical chimeric mRNAs in which the viral 5' splice site was juxtaposed to the 3' splice site of c-myb exon 2 and myb exon 1 was eliminated. Both classes of integrations generated truncated Myb proteins that were indistinguishable by Western analysis. In contrast to most other examples of c-myb activation, the truncation consisted of only 20 N-terminal amino acids and did not disrupt either the DNA binding domain near the N terminus or the negative regulatory domain near the C terminus of Myb. The significance of the 20-amino-acid Myb truncation to tumorigenesis was tested by infection of chicken embryos with retroviral vectors expressing different myb gene products. While virus expressing either wild-type c-myb or c-myb mutated at the N-terminal casein kinase II sites was only weakly oncogenic at 10 weeks, the minimally truncated myb virus induced a high incidence of rapid-onset tumors, including B-cell lymphomas, sarcomas, and adenocarcinomas.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Proc Natl Acad Sci U S A. 1985 Oct;82(20):6937-41 - PubMed
    1. Curr Top Microbiol Immunol. 1996;211:79-87 - PubMed
    1. Mol Cell Biol. 1986 Nov;6(11):3677-84 - PubMed
    1. J Virol. 1987 Apr;61(4):1203-12 - PubMed
    1. Cancer Res. 1987 Apr 15;47(8):2083-91 - PubMed

Publication types

MeSH terms

LinkOut - more resources